Similar articles

• Adult acute leukemia.

  Hoelzer D, Büchner T, Gale RP, Zittoun R. Hoelzer D, et al. Rev Invest Clin. 1994 Apr;Suppl:21-5. Rev Invest Clin. 1994. PMID: 7886303 Review. No abstract available.
• [Therapy of adult acute lymphoblastic leukemia].

  Bernasconi C. Bernasconi C. Haematologica. 1991 Jun;76 Suppl 3:58-64. Haematologica. 1991. PMID: 1752544 Review. Italian. No abstract available.
• Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

  Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hählen K, Göbel U, Klingebiel T, Ludwig WD, Henze G. Einsiedel HG, et al. J Clin Oncol. 2005 Nov 1;23(31):7942-50. doi: 10.1200/JCO.2005.01.1031. J Clin Oncol. 2005. PMID: 16258094 Clinical Trial.
• Therapy of the newly diagnosed adult with acute lymphoblastic leukemia.

  Hoelzer DF. Hoelzer DF. Hematol Oncol Clin North Am. 1993 Feb;7(1):139-60. Hematol Oncol Clin North Am. 1993. PMID: 8449856 Review.
• Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

  Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ. Harker-Murray PD, et al. Biol Blood Marrow Transplant. 2008 Jun;14(6):685-92. doi: 10.1016/j.bbmt.2008.03.011. Biol Blood Marrow Transplant. 2008. PMID: 18489994